Nav: Home

New study finds CD4 T-Cell and Blimp-1 protein critical to toxoplasmosis regulation

August 01, 2016

WASHINGTON (Aug. 1, 2016) -- New research critical to treatment for chronic toxoplasmosis, one of the most common parasitic diseases worldwide, was published in the Journal of Experimental Medicine. Researchers from the George Washington University (GW) uncovered a connection between CD8 T-cell exhaustion and CD4 T-cell exhaustion, not found before. They also discovered that CD4 T-cells can be regulated by Blimp-1 protein expression. Through regulating CD4 T-cells, CD8 T-cells can be regulated, which could lead to new therapeutic possibilities.

Toxoplasmosis is typically asymptomatic but has dangerous consequences for the immuno-suppressed and women who are pregnant. This disease is especially prevalent in HIV/AIDS populations.

"Previous research considered CD8 but not CD4 T cells to be critical in chronic toxoplasmosis control," said Imtiaz Khan, Ph.D., whose laboratory conducted this study, and professor of microbiology, immunology, and tropical medicine at the GW School of Medicine and Health Sciences. "Our research found that not only does CD4 also become exhausted during chronic toxoplasmosis, as a result of the depleted immune system, but this dysfunction is more pronounced than in CD8 T-cells. We also found CD4 exhaustion levels in contact with Blimp-1 have reduced functionality."

The data demonstrates, for the first time, that Blimp-1 is a critical regulator for CD4 T-cell exhaustion. Additionally, regulating CD4 T-cell exhaustion reverses CD8 T-cell dysfunction, resulting in improved pathogen control. This opens up new therapeutic possibilities for the millions of people experiencing chronic toxoplasmosis in developing countries and in HIV/AIDS populations. It also has important implications for cancer research.

"CD8 T-cells are also very important for protecting cancer patients," said Khan. "This research has the potential to change strategies for therapeutics against cancer. It informs ways to target CD8 T-cells, prevent CD8 T-cell exhaustion, bolster a patient's immune system, and ultimately, kill tumors."

"Blimp-1 mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic Toxoplasmosis," was published in the Journal of Experimental Medicine.
-end-
This research was funded by the National Institutes for Health.

Media: For the full study or to interview Dr. Khan, please contact Lisa Anderson at lisama2@gwu.edu or 202-994-3121.

About the GW School of Medicine and Health Sciences:

Founded in 1824, the GW School of Medicine and Health Sciences (SMHS) was the first medical school in the nation's capital and is the 11th oldest in the country. Working together in our nation's capital, with integrity and resolve, the GW SMHS is committed to improving the health and well-being of our local, national and global communities. smhs.gwu.edu

George Washington University

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#540 Specialize? Or Generalize?
Ever been called a "jack of all trades, master of none"? The world loves to elevate specialists, people who drill deep into a single topic. Those people are great. But there's a place for generalists too, argues David Epstein. Jacks of all trades are often more successful than specialists. And he's got science to back it up. We talk with Epstein about his latest book, "Range: Why Generalists Triumph in a Specialized World".
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.